Biotech Nektar to Hold Conference Call to Discuss Topline Results from the 36-Week Induction Treatment Period for its REZOLVE-AA Phase 2b Study of Rezpegaldesleukin in Alopecia Areata on December 16, 2025 December 16, 2025
Biotech Ascletis Announces Positive Topline Results from U.S. Phase I Study of ASC50, a Potential Best-in-Class Oral Small Molecule IL-17 Inhibitor December 15, 2025
Biotech Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout December 14, 2025
Biotech NanOlogy Unveils Drug Development Program for Rare Pediatric Brainstem Tumor December 13, 2025
Biotech BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair December 10, 2025
Biotech GC Genome Study Identifies ‘Confounders’ Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy December 9, 2025
Biotech The impact of avoiding recurrence: New BRAVO Study abstract at SUO 2025 demonstrates Cost Neutrality in Blue Light versus White Light Cystoscopy comparison December 8, 2025
Biotech Vivacta Bio Announces Promising First-in-Human Results for GT801, an In Vivo CAR-T Therapy, in Non-Hodgkin’s Lymphoma at the 2025 ASH Annual Meeting December 7, 2025
Search
Biotech
December 16, 2025
December 15, 2025
December 14, 2025
December 13, 2025
December 12, 2025
December 11, 2025
December 10, 2025
December 9, 2025
December 8, 2025
December 7, 2025
